20 (AIDX) Net Cash Flow (2025 - 2026)
20 (AIDX) posted Net Cash Flow of $3.2 million for Q1 2026, up 1513.16% on a QoQ basis from -$225955.0 in Q1 2025, and up 1513.16% year-over-year from $197941.1 in Q1 2025.
20 (AIDX) Net Cash Flow (2025 - 2026) Analysis & Trends
20's Net Cash Flow history runs 2 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- Quarterly Net Cash Flow rose 1513.16% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (changed N/A YoY) and the FY2025 annual result came in at -$758022.0, up 67.12% from the prior year.
- Net Cash Flow was $3.2 million for Q1 2026 at 20, up from -$225955.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $3.2 million in Q1 2026 and bottomed at -$225955.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | 20 | 3.91 Mn | -313,912.28 | 62,884.00 | 3.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.19 Mn |
| Mar 31, 2026 | 3.19 Mn |
| Mar 31, 2025 | -225,955.00 |
| Mar 31, 2025 | -225,955.00 |